RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

So long as they have a completed package, and that's the reason they have to wait for the drug stability testing to be finished--which is to some degree stability over time, so it takes time--that should not be a problem. CX-1739 has no tox legacy haunting it. Once the IND is filed, if the FDA does nothing in 30 days, it is automatically activated. In other words, and this is not irrelevant: They don't have to obtain FDA approval, so much as they have to avoid FDA disapproval.

NeuroInvestment